FindTrial
Sign In

Nalfurafine Hydrochloride

DRUG5 trials

Sponsors

Juntendo University, SK Chemicals Co., Ltd., Shenyang Sunshine Pharmaceutical Co., LTD., Chinese PLA General Hospital, Indonesia University

Conditions

Chronic Kidney Disease Associated PruritusChronic Kidney Disease-Associated Pruritus in HemodialysisChronic Renal FailureEnd Stage Renal Disease on DialysisLiver cirrhosisUremic Pruritus

Phase 1

Safety Study of TRK-820 for Patient With Hemodialysis
CompletedNCT01248650
SK Chemicals Co., Ltd.Chronic Renal Failure
Start: 2008-12-31End: 2008-12-31Updated: 2010-11-25

Phase 3

A Multi-site Bridging Study of Nalfurafine Hydrochloride Orally Disintegrating Tablet
NCT04728984
Shenyang Sunshine Pharmaceutical Co., LTD.Uremic Pruritus
Start: 2020-09-07End: 2021-10-31Target: 135Updated: 2021-01-28

Phase 4

Efficacy of Nalfurafine for Chronic Kidney Disease-Associated Pruritus in Twice-Weekly Hemodialysis Patients: A Randomized Controlled Trial
Not yet recruitingNCT07769073
Indonesia UniversityChronic Kidney Disease Associated Pruritus, End Stage Renal Disease on Dialysis
Start: 2026-08-17End: 2026-10-13Target: 36Updated: 2026-08-17

Unknown Phase

Alternate-day oral therapy with Nalfurafine hydrochloride as refractory pruritus for liver cirrhotic patients
Active, not recruitingJPRN-UMIN000023638
Juntendo UniversityLiver cirrhosis
Start: 2016-08-16Target: 30Updated: 2026-06-29
Clinical Study on the Efficacy and Safety of Nalfurafine Hydrochloride Orally Disintegrating Tablets in Treating Pruritus in Patients Undergoing Maintenance Hemodialysis
Not yet recruitingNCT07650851
Chinese PLA General HospitalChronic Kidney Disease-Associated Pruritus in Hemodialysis
Start: 2026-07-01End: 2028-12-31Target: 150Updated: 2026-06-16